ASX:LFR Longford Resources (LFR) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free LFR Stock Alerts Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume253,956 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Longford Resources alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Longford Resources Stock (ASX:LFR)Longford Resources Limited, formerly Ram Resources Limited, is engaged in the exploration of mineral properties in Australia. The Company's segments include Australia and Greenland. The Company's projects include Fraser Range North, Telfer Projects, West Kimberley and Fraser Range Project. The Fraser Range North Project is located in the Fraser Range and covers approximately 163 square kilometers with over five tenements within the Fraser Zone of the Albany-Fraser Orogen. The Fraser Range North project contains four Bed rock conductors. The Fraser Range Project consists of E28/2210, E28/2209 and E63/1528 tenements. The Company also holds option to purchase 100% interest in E28/2299, E28/2300, E28/2301, E28/2320 and E28/2321 tenements in the Fraser Range North Project. Telfer Project consists of exploration licenses E45/2726 and E45/2727, which are located over 400 kilometers east-southeast of Port Hedland in Western Australia. The West Kimberley project consists of EL 04/2423 tenement.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> LFR Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive LFR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Longford Resources and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/02/2017Today4/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorN/A Industry N/A Sub-IndustryN/A Current SymbolASX:LFR Previous SymbolASX:RMR CUSIPN/A CIKN/A Webwww.longfordresources.com Phone+61-8-93161016FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMichael HaynesManaging Director, DirectorIan CunninghamCompany SecretaryEryn KestelCompany SecretaryRichard HillNon-Executive Chairman of the BoardScott MisonNon-Executive Director LFR Stock Analysis - Frequently Asked Questions How were Longford Resources' earnings last quarter? Longford Resources Limited (ASX:LFR) issued its quarterly earnings data on Monday, October, 2nd. The company reported ($0.01) EPS for the quarter. What other stocks do shareholders of Longford Resources own? Based on aggregate information from My MarketBeat watchlists, some companies that other Longford Resources investors own include ALDW (ALDW), Alder Biopharmaceuticals (ALDR), Apollo Investment (AINV), AGNC Investment (AGNC), Allergan (AGN), Agios Pharmaceuticals (AGIO), Ayala Pharmaceuticals (ADXS), Accenture (ACN) and ACADIA Pharmaceuticals (ACAD). This page (ASX:LFR) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longford Resources Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.